NCT04224116View on ClinicalTrials.gov

Tranexamic Acid Contribution in the Prevention of Perioperative Bleeding in Thoracic Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

October 2, 2019

Study Completion Date

October 2, 2019

Conditions
Bleeding
Interventions
DRUG

Tranexamic acid injection

to receive tranexamic acid (25mg/kg) in bolus at induction followed by 2mg/kg/h in continuous infusion until the end of the act.

DRUG

SSI

Serum Salin isotonic injected

All Listed Sponsors
lead

University Tunis El Manar

OTHER

NCT04224116 - Tranexamic Acid Contribution in the Prevention of Perioperative Bleeding in Thoracic Surgery | Biotech Hunter | Biotech Hunter